Association between tumor infiltrating lymphocytes (TILs) and the HER2DX assay in early-stage of HER2-positive (HER2+) breast cancer
Esther Sanfeliu,Fara Braso-Maristany,Maria Vittoria Dieci,Mercedes Marin-Aguilera,Blanca Gonzalez-Farre,Gaia Griguolo,Tomas Pascual,Patricia Galvan,Laura Angelats, Oleguer Castillo, Paula Blasco,Valeria Sirenko,Pedro Jares,Joan Anton Puig-Butille,Laia Pare,Antonio Martinez,Antonio Llombart-Cussac,Javier Cortes,Ana Vivancos,Patricia Villagrasa,Joel S. Parker,Charles M. Perou,Aleix Prat,PierFranco Conte,Valentina Guarneri CANCER RESEARCH(2023)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)